Tag Archives: patient monitoring

Tales from the Road – Arab Health

We’ve just departed from Dubai having completed a very successful Arab Health exposition. The Vasomedical booth included displays, graphics and demonstrations from all segments of our company profile, including EECP® and ECP therapy systems, Biox’ new ECG Holter and ambulatory blood pressure monitors and our wireless MobiCare™ patient monitoring products. Our booth location was ideal, we were in one of the convention center’s main concourses and was extremely busy throughout the whole show. We were joined in the booth by our associates from Biox and VSK, Vasomedical’s newest joint venture for marketing and sales of EECP/ECP technology globally. Together we welcomed many visitors from all over the Middle East, as well as visitors from North America, Europe and India.

This show allowed us to increase our exposure in the Middle East. There are treatment centers in the Kingdom of Saudi Arabia, the United Arab Emirates, Egypt, Jordan, the Sudan, Bahrain, Oman and Israel. Many physicians in the region are familiar with the clinical benefits of the therapy and are very interested in bringing the technology to their local hospitals and clinics.

Biox – MobiCare™ wireless patient monitoring products attracted a high level of interest at the show. The flexibility to un-tether the patient from the monitor using Bluetooth technology is very unique. Along with the added feature of remote viewing capabilities away from the clinical setting by physicians, healthcare workers and patient families, it was evident that MobiCare™ was one of the most interesting new products seen by many of the attendees.

Tales From the Road: Medical Fair Asia 2014

As Medical Fair Asia comes to a close in Singapore on Sept 11th, 2014, many of us are reflecting on this day. 13 years ago millions of people went to sleep not knowing the world was about to change forever. We continue to think about the people we lost that day and will keep them and their families in our thoughts, our hearts and our prayers.

Medical Fair Asia has been another successful meeting. There were constant visitors to our booth, they came from all over Southeast Asia to participate in this show, which is one of the largest medical industry conferences in the Asian market.  Hospital and healthcare administrators, physicians and many distributors came to our booth wanting to see our products; they were especially interested in MobiCare®, a unique wireless patient monitoring system with flexible communications capabilities.

MobiCare frees the patients from typical bedside monitoring and allows them the freedom to move about the room and nearby areas with comfort and safety. In addition, the ability to perform remote viewing functions by authorized personnel expanded the potential capabilities to meet multiple needs of a quickly growing and more challenging healthcare marketplace. The need for safe and reliable monitoring for patients is no longer limited to bedside monitoring in the hospital, nor does it stop when the patient is discharged. There is a rapidly growing need to provide better medical services in some of the most unique situations and MobiCare’s communication flexibility meets that monitoring challenge head on.

Though there have been a few scattered EECP Therapy systems throughout the region, EECP Therapy is not generally well known in Southeast Asia. Some of our distributors visited us to discuss opportunities and projects they are currently working on and plans to expand awareness in their designated territories. While most healthcare professionals in the region are not aware of the therapy, our participation in international shows expands awareness of the therapy and is creating a bigger audience for its acceptance. Many new distributors visited our booth and expressed interest in becoming our authorized representative in their respective countries for EECP Therapy, as well as our Biox ECG Holter and ambulatory monitoring products.

We also had an opportunity to learn more about the regulatory and typical marketing practices in many of the countries represented here. Having a better understanding and establishing connections in this region will help us ensure we approach the markets in the best way possible to create opportunities to generate revenue, while controlling and monitoring expenses.

Make sure to stay tuned for more tales from the road as we continue to showcase and educate the healthcare industry about EECP Therapy technology and our other offerings.

Tales from the Heart – EECP® on Prime Time TV

Last week in Los Angeles, TV station KTLA ran a live broadcast from Global Cardio Care, an Inglewood based EECP® therapy clinic that has been treating patients with cardiovascular disease since 2002. Sara Soulati, founder of Global Cardio Care has been treating patients since 1996 when she launched her career in the field of EECP® therapy. After treating thousands of patients successfully in her West LA location Sara opened up a second center in 2012 in the Wilshire area of West LA.

Sara’s centers offer a healthy life style program featuring EECP® therapy, plant-based nutrition and exercise. EECP® therapy, an FDA cleared therapy for the treatment of angina and used for other cardiovascular diseases as well, has been clinically proven though still remains relatively unknown. You can visit the KTLA web site and read the story as well as see the videos of the segments on EECP® therapy as seen by the public in the Los Angeles viewing area last Friday.

It was so well viewed in Los Angeles that Jay Leno used a sequence shot in his ‘Looks Dirty But It’s Not” comedy routine. Hopefully this exposure on KTLA can help make more patients aware of the therapy and increase their interest to find access to a therapy center near them. As Gayle and Sara demonstrated, you may find that EECP® therapy can create a New Year! New You!

We Need To Be Proactive About Our Heart Health

The Center for Disease Control and Prevention (CDC) recently released a report declaring that nearly a quarter of deaths that occur each year as a result of heart disease and stroke are, in fact, preventable. The CDC noted that more than 200,000 people ages 75 and younger died from heart disease and stroke in 2010; and these lives could have been saved with more effective public health measures, treatments and simple lifestyle changes.

One reason for the high rates of preventable deaths is that young adults are normally less likely to receive health screenings and get early treatments for conditions such as high blood pressure and cholesterol, which are major risk factors that can lead to heart disease and stroke. This report should be a wake-up call for everyone to be more proactive in taking care of themselves, which can be as simple and easy as eating healthy and exercising on a regularly basis.

Regarding appropriate medical treatments, the report findings by the CDC create an opportunity for us at Vasomedical to generate awareness and educate the wider public about the benefits of EECP Therapy. With EECP Therapy, the leading non-pharmacological, non-invasive therapy, around 75-80 percent of patients realize the initial therapeutic benefits – including the elimination or reduction of symptoms such as chest pain, breathlessness and fatigue, among many other benefits – upon completion of their therapy. Clinical studies have shown that the benefits can last longer than three years. EECP Therapy carries few risk complications and is dramatically less expensive than leading invasive procedures.  For those suffering from heart disease, EECP Therapy can be a lifesaver and provides a significantly better quality of life.

It’s always good to be ahead of the curve, so take pride in your well-being and heart health. Together we can reduce the amount of preventable deaths in the U.S. and enjoy long, fulfilling and healthy lives.

Medicare to Punish Hospitals for Excess Readmissions

Medicare, under the new healthcare legislation,is taking steps to crack down on excessive readmissions with the goals of increasing quality of care, reducing costs and minimizing the number of trips back to the hospital patients will have to make.

According to an article by Jordan Rau in Kaiser Health News, Medicare has identified 2,225 hospitals that will have their Medicare payments reduced by up to 1 percent as a result of the fines imposed under the penalty provisions of the current Patient Protection and Affordable Care Act (PPACA) this year. Eighteen hospitals will lose 2 percent, the maximum penalty allowed under the new legislation for one year starting on October 1, 2013. The penalty program, which began one year ago, is designed to pay hospitals for the quality of their performance, not simply the number of patients they treat.

The program this year started by punishing hospitals for unplanned patient readmissions within 30 days after initial treatment for those treated and released for heart attacks, heart failure and pneumonia.

Based upon the first year’s results some large hospitals may lose more than $1 million in penalties. Also, hospitals that avoided the penalties may have even lost more in revenue due to their reduced admissions. Obviously, the hospitals are not too happy about this plan, especially those hospitals that treat large numbers of lower income patients. Low-income patients have a harder time following their post discharge instructions due to the cost of buying expensive medications, not fully understanding discharge instructions, or having the means to support a particular diet to avoid congestive heart failure.

Hospitals have taken additional steps, such as hiring more staff to follow up with patients outside the hospital to avoid these readmissions or giving them free medication upon discharge, as Medicare does not pay for these services. When one looks at this picture it just begs the question: why wouldn’t hospitals be more receptive to adding alternative therapies – such as EECP® Therapy – to their services so that they could also realize the same significant reduction in hospital readmissions that have been demonstrated in clinical studies, such as one authored by  Dr. Ozlem Soran at the University of Pittsburgh?

EECP Therapy is a proven treatment that will reduce hospital re-admissions. Now we need to persuade hospitals to jump on the EECP Therapy bandwagon by adding EECP Therapy services in their clinical departments or hospital owned physician practices.

Tales from the Road: Hospitalar 2013

After three days of exhibiting at the Hospitalar 2013 meeting in São Paulo, we are even more convinced that Brazil will be an excellent market for EECP Therapy!

At the exhibition, Vasomedical displayed and demonstrated its core technology, EECP Therapy, its Biox ambulatory monitoring products and its EZ series patient management products. Visiting physicians and healthcare professionals expressed particular interest in how EECP technology can help patients with cardiovascular disease as well as significantly reduce healthcare costs.

We met with attendees from across the globe who were extremely pleasant and welcoming to the Vasomedical team and our products. It was a great experience participating in this event and understanding how we can expand our presence in South America.

The icing on the cake: we are in the process of registering Vasomedical and Biox products for sale in Brazil, putting us in a great position to build relationships for the near future!

Make sure to stay tuned for more tales from around the globe as we continue to showcase and educate the healthcare industry about EECP Therapy technology and our other offerings.

Next stop: New York, NY!